Methadone Market Share

  • Report ID: 3793
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Methadone Market - Regional Analysis

North American Market Insights

 North America industry is likely to account for largest revenue share of 42% by 2035, driven by increasing cases of drug addiction in the region.. According to the Centre for Disease Control and Prevalence (CDC) in 2019, 70,630 deaths were caused by drug overdose in the United States. Additionally, the increased prevalence of misery and the increase in substance abuse cases, have further fueled regional expansion. High distress is also associated with an increase in the number of patients using methadone to treat persistent post-operative pain.

APAC Market Insights

On the other, the market in the Asia-Pacific region is expected to have significant growth in the forecast period. This is owing to the fact that India and China are countries that have high populations, especially geriatric ones. This indicates that people in these countries have chances to get affected by chronic diseases which in turn will drive the growth of the market in the upcoming time.

Europe Market Insights

The market in the Europe region is estimated to have steady growth in the forecast period. This is ascribed owing to the high obtainment of analgesics. Factors such as the high population suffering from chronic and respiratory diseases in this region are driving the growth of this market in the European region. As discussed in the previous part that methadone helps to treat quite a lot of chronic diseases as well as gives relief to deadly pain the body is suffering from.

Methadone Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of methadone is assessed at USD 206.85 million.

The global methadone market size was valued at more than USD 193.93 million in 2025 and is expected to register a CAGR of over 7.4%, exceeding USD 395.99 million revenue by 2035.

North America methadone market is projected to secure a 42% revenue share, spurred by the rising incidence of drug addiction and the growing reliance on methadone for managing post-operative and substance-related pain.

Key players in the market include Eli Lilly and Company, Sanofi S.A., Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., BioControl Medical, Tianjin Central Pharmaceutical Industry Co., Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos